Citations

Clear

58 citation(s) found for "Nelson, Heidi".

Local excision for rectal cancer
Stewart, Andrew K., Nelson, Heidi, Baxter, Nancy Noel

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3615-3615

10.1200/jco.2004.22.90140.3615 Get It

Comparison of Fecal Collection Methods for Microbiota Studies in Bangladesh
Vogtmann, Emily , Chen, Jun , Chen, Yu , Eunes, Mahbubul, Ahmed, Alauddin , Naher, Jabun, Rahman, Anisur, Amir, Amnon , Shi, Jianxin , Abnet, Christian C. , Nelson, Heidi , Knight, Rob , Ahsan, Habibul , Chia, Nicholas , Kibriya, Muhammad Ghulam , Islam, Tariqul , Chia, Nicholas , Sinha, Rashmi R. , Abnet, Christian C , Chen, Yu

Mayo Clinic

Applied and Environmental Microbiology | March 4, 2017 | Volume: 83 | Issue: 10 | Pages: No page available

10.1128/aem.00361-17 | PMID 28258145 Get It

ABSTRACT To our knowledge, fecal microbiota collection methods have not been evaluated in low- and middle-income countries. Therefore, we evaluated five different fecal sample collection methods for technical reproducibility, stability, and accuracy within the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Fifty participants from the HEALS provided fecal samples in the clinic which were aliquoted into no solution, 95% ethanol, RNAlater, postdevelopment fecal occult blood test (FOBT) cards, and fecal immunochemical test (FIT) tubes. Half of the aliquots were frozen immediately at −80°C (day 0) and the remaining samples were left at ambient temperature for 96 h and then frozen (day 4). Intraclass correlation coefficients (ICC) were calculated for the relative abundances of the top three phyla, for two alpha diversity measures, and for four beta diversity measures. The duplicate samples had relatively high ICCs for technical reproducibility at day 0 and day 4 (range, 0.79 to 0.99). The FOBT card and samples preserved in RNAlater and 95% ethanol had the highest ICCs for stability over 4 days. The FIT tube had lower stability measures overall. In comparison to the “gold standard” method using immediately frozen fecal samples with no solution, the ICCs for many of the microbial metrics were low, but the rank order appeared to be preserved as seen by the Spearman correlation. The FOBT cards, 95% ethanol, and RNAlater were effective fecal preservatives. These fecal collection methods are optimal for future cohort studies, particularly in low- and middle-income countries. IMPORTANCE The collection of fecal samples in prospective cohort studies is essential to provide the opportunity to study the effect of the human microbiota on numerous health conditions. However, these collection methods have not been adequately tested in low- and middle-income countries. We present estimates of technical reproducibility, stability at ambient temperature for 4 days, and accuracy comparing a “gold standard” for fecal samples in no solution, 95% ethanol, RNAlater, postdevelopment fecal occult blood test cards, and fecal immunochemical test tubes in a study conducted in Bangladesh. Fecal occult blood test cards and fecal samples stored in 95% ethanol or RNAlater adequately preserve fecal samples in this setting. Therefore, new studies in low- and middle-income countries should include collection of fecal samples using fecal occult blood test cards, 95% ethanol, or RNAlater for prospective cohort studies.
Impact of Surgical and Pathologic Variables in Rectal Cancer: A United States Community and Cooperative Group Report
Stocchi, Luca , Nelson, Heidi , Tepper, Joel E. , Krook, James E., Beart, Robert W., Group, the North Central Cancer Treatment, Sargent, Daniel J. , O’Connell, Michael J. , Group, the North Central Cancer Treatment

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 19 | Issue: 18 | Pages: 3895-3902

10.1200/jco.2001.19.18.3895 | PMID 11559727 Get It

PURPOSE: Substantial and successful effort has been focused on decreasing the risk of local failure after rectal cancer surgery through the use of adjuvant therapies. Our study examined data from studies conducted by United States cooperative groups to investigate the impact of surgical and pathologic variables in rectal cancer outcomes. PATIENTS AND METHODS: Surgical and pathologic reports from 673 patients with stage II/III rectal cancer enrolled onto three adjuvant clinical trials were reviewed for tumor and surgical variables. Additional information on individual institutions and operating surgeon was collected. Variables were tested for association with 5-year local recurrence and survival after adjustment for adjuvant treatments and other important prognostic factors. RESULTS: Five-year local recurrence and survival rates were 16% and 59%, respectively. Surgeons treating more than 10 study cases had lower local recurrence rates than those treating ≤ 10 (11% v 17%, P = .02). Free radial margins also correlated with local recurrence (P = .01). Type of surgery, distal margins, and tumor radial spread were not significant. Tumor adherence to adjacent structures predicted local recurrence (35% v 14%, P < .001) and survival (30% v 63%, P < .001), regardless of en bloc resection. Although T and N classification predicted survival (P < .001), only N classification correlated with local recurrence. The number and percentage of positive nodes correlated with survival, but only the percentage independently predicted local recurrence. Several pathologic and surgical variables were reported suboptimally. CONCLUSION: Moderate variability in outcomes among surgeons was detected in this high-risk population. Efforts to improve surgical results will require changes in reporting practices to allow for more accurate assessment of the quality of surgery.
Evidence in Favor of Standard Surgical Treatment for Rectal Cancer
Nelson, Heidi D , Machairas, Nikolaos , Grothey, Axel

Mayo Clinic

JAMA Oncology | December 22, 2016 | Volume: 3 | Issue: 7 | Pages: 885

10.1001/jamaoncol.2016.5397 | PMID 28006064 Get It

Shifts in the Fecal Microbiota Associated with Adenomatous Polyps
Hale, Vanessa L. , Johnson, Stephen , Harrington, Sean C., Yab, Tracy C. , Smyrk, Thomas C. , Nelson, Heidi , Boardman, Lisa A., Druliner, Brooke R., Levin, Theodore R. , Rex, Douglas K. , Ahnen, Dennis J. , Lance, Peter , Ahlquist, David A. , Chia, Nicholas , Chen, Jun , Boardman, Lisa A., Druliner, Brooke R. , Chia, Nicholas

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | September 26, 2016 | Volume: 26 | Issue: 1 | Pages: 85-94

10.1158/1055-9965.epi-16-0337 | PMID 27672054 Get It

Abstract Background: Adenomatous polyps are the most common precursor to colorectal cancer, the second leading cause of cancer-related death in the United States. We sought to learn more about early events of carcinogenesis by investigating shifts in the gut microbiota of patients with adenomas. Methods: We analyzed 16S rRNA gene sequences from the fecal microbiota of patients with adenomas (n = 233) and without (n = 547). Results: Multiple taxa were significantly more abundant in patients with adenomas, including Bilophila, Desulfovibrio, proinflammatory bacteria in the genus Mogibacterium, and multiple Bacteroidetes species. Patients without adenomas had greater abundances of Veillonella, Firmicutes (Order Clostridia), and Actinobacteria (family Bifidobacteriales). Our findings were consistent with previously reported shifts in the gut microbiota of colorectal cancer patients. Importantly, the altered adenoma profile is predicted to increase primary and secondary bile acid production, as well as starch, sucrose, lipid, and phenylpropanoid metabolism. Conclusions: These data hint that increased sugar, protein, and lipid metabolism along with increased bile acid production could promote a colonic environment that supports the growth of bile-tolerant microbes such as Bilophilia and Desulfovibrio. In turn, these microbes may produce genotoxic or inflammatory metabolites such as H2S and secondary bile acids, which could play a role in catalyzing adenoma development and eventually colorectal cancer. Impact: This study suggests a plausible biological mechanism to explain the links between shifts in the microbiota and colorectal cancer. This represents a first step toward resolving the complex interactions that shape the adenoma–carcinoma sequence of colorectal cancer and may facilitate personalized therapeutics focused on the microbiota. Cancer Epidemiol Biomarkers Prev; 26(1); 85–94. ©2016 AACR.
Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies
Loftfield, Erikka , Vogtmann, Emily , Moore, Steven C. , Nelson, Heidi , Knight, Rob , Chia, Nicholas , Sampson, Joshua N. , Chia, Nicholas , Sinha, Rashmi R. , Moore, Steven C

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | August 19, 2016 | Volume: 25 | Issue: 11 | Pages: 1483-1490

10.1158/1055-9965.epi-16-0409 | PMID 27543620 Get It

Abstract Background: The gut metabolome may be associated with the incidence and progression of numerous diseases. The composition of the gut metabolome can be captured by measuring metabolite levels in the feces. However, there are little data describing the effect of fecal sample collection methods on metabolomic measures. Methods: We collected fecal samples from 18 volunteers using four methods: no solution, 95% ethanol, fecal occult blood test (FOBT) cards, and fecal immunochemical test (FIT). One set of samples was frozen after collection (day 0), and for 95% ethanol, FOBT, and FIT, a second set was frozen after 96 hours at room temperature. We evaluated (i) technical reproducibility within sample replicates, (ii) stability after 96 hours at room temperature for 95% ethanol, FOBT, and FIT, and (iii) concordance of metabolite measures with the putative “gold standard,” day 0 samples without solution. Results: Intraclass correlation coefficients (ICC) estimating technical reproducibility were high for replicate samples for each collection method. ICCs estimating stability at room temperature were high for 95% ethanol and FOBT (median ICC &gt; 0.87) but not FIT (median ICC = 0.52). Similarly, Spearman correlation coefficients (rs) estimating metabolite concordance with the “gold standard” were higher for 95% ethanol (median rs = 0.82) and FOBT (median rs = 0.70) than for FIT (median rs = 0.40). Conclusions: Metabolomic measurements appear reproducible and stable in fecal samples collected with 95% ethanol or FOBT. Concordance with the “gold standard” is highest with 95% ethanol and acceptable with FOBT. Impact: Future epidemiologic studies should collect feces using 95% ethanol or FOBT if interested in studying fecal metabolomics. Cancer Epidemiol Biomarkers Prev; 25(11); 1483–90. ©2016 AACR.
Impact of demographics on human gut microbial diversity in a US Midwest population
Ryu, Euijung , Hathcock, Matthew , Nelson, Heidi , Ballman, Karla, Chia, Nicholas , Chen, Jun , Ballman, Karla V. , Chia, Nicholas , Olson, Janet E.

Mayo Clinic

PeerJ | January 7, 2016 | Volume: 4 | Issue: No issue available | Pages: e1514

10.7717/peerj.1514 | PMID 26839739 Get It

The clinical utility of microbiome biomarkers depends on the reliable and reproducible nature of comparative results. Underappreciation of the variation associated with common demographic, health, and behavioral factors may confound associations of interest and generate false positives. Here, we present the Midwestern Reference Panel (MWRP), a resource for comparative gut microbiome studies conducted in the Midwestern United States. We analyzed the relationships between demographic and health behavior-related factors and the microbiota in this cohort, and estimated their effect sizes. Most variables investigated were associated with the gut microbiota. Specifically, body mass index (BMI), race, sex, and alcohol use were significantly associated with microbial β-diversity (P < 0.05, unweighted UniFrac). BMI, race and alcohol use were also significantly associated with microbial α-diversity (P < 0.05, species richness). Tobacco use showed a trend toward association with the microbiota (P < 0.1, unweighted UniFrac). The effect sizes of the associations, as quantified by adjusted R 2 values based on unweighted UniFrac distances, were small (< 1% for all variables), indicating that these factors explain only a small percentage of overall microbiota variability. Nevertheless, the significant associations between these variables and the gut microbiota suggest that they could still be potential confounders in comparative studies and that controlling for these variables in study design, which is the main objective of the MWRP, is important for increasing reproducibility in comparative microbiome studies.
Seromuscular Colonic Flap for Intrapelvic Soft-Tissue Coverage: A Reconstructive Option for Plastic Surgeons When Traditionally Used Flaps Are Not Available
Aho, Johnathon M. , Winocour, Sebastian, Hammoudeh, Ziyad S. , Nelson, Heidi , Rose, Peter S. , Tran, Nho V. , Aho, Johnathon, Rose, Peter

Mayo Clinic

Case Reports in Surgery | November 24, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/563641 | PMID 26688771 Get It

Background. Reconstruction of intrapelvic defects can be a challenging problem in patients with limited regional muscle flap options and previously resected omentum. In such situations, alternative methods of mobilizing vascularized tissue may be required.Methods. A case of a patient that underwent pelvic extirpation for recurrent rectal cancer who had limited donor sites for flap reconstruction is presented. The mucosa was removed from a blind loop of colon, and a pedicled seromuscular flap based on the colonic mesentery was placed into the pelvis for vascularized soft-tissue coverage and elimination of dead space.Results. The postoperative course was only complicated by a small subcutaneous fluid collection beneath the sacrectomy skin incision, which was drained with radiological assistance. The patient recovered without any major postoperative complications.Conclusion. Seromuscular colonic flap is a useful option for soft-tissue coverage after pelvic extirpation and should be considered by plastic surgeons when other reconstruction options are not available.
Young Age and Aggressive Treatment in Colon Cancer
Berian, Julia R. , Benson, Al B. , Nelson, Heidi

Mayo Clinic

JAMA | August 11, 2015 | Volume: 314 | Issue: 6 | Pages: 613

10.1001/jama.2015.9379 | PMID 26262799 Get It